Search Within

Maura N Dickler

Formats
  1. Meeting Abstract (141)
  2. Journal Article (115)
  3. Book Section (5)
  4. Conference Paper (1)
  5. Review (1)
Groups
  1. Department of Medicine (169)
  2. Solid Tumor Oncology Division (163)
  3. Breast Medicine Service (155)
  4. Survivorship Research (152)
  5. Epidemiology and Biostatistics (105)
  6. Population Sciences Research Program (89)

More Groups

People
  1. Clifford Hudis (102)
  2. Larry Norton (64)
  3. Shari Goldfarb (51)
  4. Chau Dang (39)
  5. Sujata Patil (35)
  6. Tiffany Traina (34)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (6)
  4. 2019 (4)
  5. 2018 (20)
  6. 2017 (29)

More Years

Publications
  1. Journal of Clinical Oncology (69)
  2. Cancer Research (41)
  3. Breast Cancer Research and Treatment (18)
  4. Clinical Cancer Research (14)
  5. Annals of Oncology (10)
  6. Journal of Sexual Medicine (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. American Association for Cancer Research (57)
  3. Springer (26)
  4. Elsevier Inc. (18)
  5. Oxford University Press (18)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (263)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Do biomarker changes during neoadjuvant endocrine therapy reflect breast tumor receptor status?
    Journal Article

    Dickler, M.
    Nature Clinical Practice Oncology (2005)

    Fulltext@MSK | Save
  • Circulating endothelial cell (CEC) and tumor cell (CTC) analysis in patients (pts) receiving bevacizumab and erlotinib for metastatic breast cancer (MBC)
    Meeting Abstract

    Rugo, H. S.; Dickler, M. N.; Scott, J. H.; Moore, D. H.; Park, J. W.
    Breast Cancer Research and Treatment (2004)

    Fulltext@MSK | Save
  • Phase II trial of erlotinib (OSI-774), an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor, and bevacizumab, a recombinant humanized monoclonal antibody to vascular endothelial growth factor (VEGF), in patients (pts) with metastatic breast cancer (MBC)
    Meeting Abstract

    Dickler, M.; Rugo, H.; Caravelli, J.; Brogi, E.; Sachs, D.; Panageas, K.; Flores, S.; Moasser, M.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Maximizing the potential of bevacizumab in cancer treatment
    Journal Article

    Bergsland, E.; Dickler, M. N.
    The Oncologist (2004)

    Fulltext@MSK | Save
  • Aromatase inhibitors for hormonal therapy of early-stage breast cancer
    Journal Article

    Traina, T. A.; Dickler, M. N.
    Current Opinion in Investigational Drugs (2004)

    Fulltext@MSK | Save
  • Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments
    Journal Article

    Dang, C. T.; Dannenberg, A. J.; Subbaramaiah, K.; Dickler, M. N.; Moasser, M. M.; Seidman, A. D.; D'Andrea, G. M.; Theodoulou, M.; Panageas, K. S.; Norton, L.; more...
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer
    Journal Article

    Dang, C. T.; D'Andrea, G. M.; Moynahan, M. E.; Dickler, M. N.; Seidman, A. D.; Fornier, M.; Robson, M. E.; Theodoulou, M.; Lake, D.; Currie, V. E.; more...
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer
    Journal Article

    Esteva, F. J.; Glaspy, J.; Baidas, S.; Laufman, L.; Hutchins, L.; Dickler, M.; Tripathy, D.; Cohen, R.; DeMichele, A.; Yocum, R. C.; more...
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Occult central nervous system involvement in patients with metastatic breast cancer: Prevalence, predictive factors and impact on overall survival
    Journal Article

    Miller, K. D.; Weathers, T.; Haney, L. G.; Timmerman, R.; Dickler, M.; Shen, J.; Sledge, G. W. Jr
    Annals of Oncology (2003)

    Fulltext@MSK | Save
  • Effects of exemestane and raloxifene on breast density by mammography and MRI in postmenopausal women: Preliminary data from a pilot chemoprevention trial
    Meeting Abstract

    Dickler, M.; Morris, E.; Robson, M.; Choi, J.; Hummer, A.; Panageas, K.; Ballon, D.; Borgen, P.; Norton, L.; Hudis, C.
    Cancer Epidemiology Biomarkers and Prevention (2002)

    Fulltext@MSK | Save